ARCHIVES

J&J Withdraws Power Morcellators, Citing Risk of Disseminating Cancer

This article is from The Cancer Letter archive.

Vol. 40 No. 31 | August 1, 2014

Download PDF Visit The Full Archive

Related Articles

Clinical Trials: NIH Health Plans Association, Agree In Principle to Raise Clinical Trial Enrollment

March 5, 1999

Guest Editorial: Anil Potti Hires “Online Reputation Managers” As Journals Retract His Biomarker Research

April 15, 2011

NCI’s SBIR Paylines Nears Regular Grants

September 20, 1985

Prevention, Centers To Gain, some $$ In President’s Budget

February 8, 1991

Metastasis Research Is Example Of Progress Under 1971 Cancer Act

May 10, 1991

FDA Seeks Consumers For Advisory Committees.

November 23, 2001